Literature DB >> 33768442

Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis.

Yiguo Zhou1, Yi-Fan Lin1, Lei Gao2, Jianghong Dai3, Ganfeng Luo1, Lanying Li4, Tanwei Yuan1, Peiyang Li5, Yuewei Zhan1, Yanxiao Gao1, Huachun Zou6,7.   

Abstract

Human papillomavirus (HPV) infection among men who have sex with men (MSM) in China is underreported. We performed a systematic review and meta-analysis to clarify site-specific HPV prevalence among MSM in China. We searched both English and Chinese databases for all studies published before April 1, 2020, that reported HPV prevalence among MSM in China. Random-effects meta-analysis was used to calculate summary estimates. Thirty-four articles were eligible, where 32, 5, and 2 articles reported HPV prevalence at the anus, penis, and oral cavity, respectively. The estimated prevalence of anal HPV among MSM in China was 85.1% (HIV-positive), 53.6% (HIV-negative), and 59.2% (unknown HIV status), with HPV genotypes being predominated by HPV 6, 11, 16, 18, 52, and 58. Any HPV and high-risk (HR) HPV was more common in northern China, while low-risk HPV was more common in southern China. HPV prevalence increased with age among HIV-negative MSM, from 40.5% (aged < 20 years) to 57.2% (aged ≥ 40 years). High prevalence of any HPV (HIV+: 95.1%; HIV-: 97.7%) and multiple infections (HIV+: 75.9%; HIV-: 41.7%) was found in anogenital warts among MSM. HPV is common among MSM in China. MSM living with HIV and/or anogenital warts were at disproportionate risk for HR HPV. Younger MSM were found to have a lower HPV prevalence. HPV vaccines would have prevented the majority of infections if given before sex debut. HPV at anatomical sites other than the anus, incident HPV infection, and the cost-effectiveness of HPV vaccination in this population are worth further investigation.

Entities:  

Keywords:  China; Human immunodeficiency virus; Human papillomavirus; Men who have sex with men; Prevalence

Year:  2021        PMID: 33768442     DOI: 10.1007/s10096-021-04229-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.

Authors:  Xiaomeng Ma; Qian Wang; Jason J Ong; Christopher K Fairley; Shu Su; Peng Peng; Jun Jing; Linhong Wang; Nyi Nyi Soe; Feng Cheng; Lei Zhang
Journal:  Sex Transm Infect       Date:  2018-05-24       Impact factor: 3.519

Review 2.  Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

Authors:  Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich
Journal:  Lancet Oncol       Date:  2012-03-23       Impact factor: 41.316

3.  Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis.

Authors:  Elske Marra; Chunqing Lin; Gary M Clifford
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

4.  Oral human papillomavirus infection in HIV-negative and HIV-infected MSM.

Authors:  Sofie H Mooij; Hein J Boot; Arjen G C L Speksnijder; Ineke G Stolte; Chris J L M Meijer; Peter J F Snijders; Dominique W M Verhagen; Audrey J King; Henry J C de Vries; Wim G V Quint; Marianne A B van der Sande; Maarten F Schim van der Loeff
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

5.  Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men.

Authors:  Stephen Goldstone; Joel M Palefsky; Anna R Giuliano; Edson D Moreira; Carlos Aranda; Heiko Jessen; Richard J Hillman; Daron G Ferris; Francois Coutlee; Kai-Li Liaw; J Brooke Marshall; Xuehong Zhang; Scott Vuocolo; Eliav Barr; Richard M Haupt; Dalya Guris; Elizabeth I O Garner
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 6.  The epidemiology of genital human papillomavirus infection.

Authors:  Helen Trottier; Eduardo L Franco
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

7.  Beyond cervical cancer: burden of other HPV-related cancers among men and women.

Authors:  Anil K Chaturvedi
Journal:  J Adolesc Health       Date:  2010-04       Impact factor: 5.012

Review 8.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

Authors:  Silvia de Sanjosé; Mireia Diaz; Xavier Castellsagué; Gary Clifford; Laia Bruni; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Infect Dis       Date:  2007-07       Impact factor: 25.071

9.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

10.  Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status.

Authors:  Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

View more
  5 in total

1.  Natural History of Anal Papillomavirus Infection in HIV-Negative Men Who Have Sex With Men Based on a Markov Model: A 5-Year Prospective Cohort Study.

Authors:  Zewen Zhang; Xi Ling; Lirong Liu; Miaomiao Xi; Guozhen Zhang; Jianghong Dai
Journal:  Front Public Health       Date:  2022-05-11

Review 2.  Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.

Authors:  Supitcha Kamolratanakul; Punnee Pitisuttithum
Journal:  Vaccines (Basel)       Date:  2021-11-30

3.  Reinfection of Nine-Valent Human Papillomavirus Vaccine Types Among HIV-Negative Men Who Have Sex With Men: A Prospective Cohort Study.

Authors:  Lirong Liu; Guozhen Zhang; Zewen Zhang; Lu Wang; Duolao Wang; Jianghong Dai
Journal:  Front Public Health       Date:  2022-07-18

4.  Incidence, Persistence, and Clearance of Anal Human Papillomavirus among Men Who Have Sex with Men in China: An Observational Cohort Study.

Authors:  Yiguo Zhou; Xinyi Zhou; Yi-Fan Lin; Ganfeng Luo; Yong Lu; Zhenyu Wang; Peiyang Li; Zhenzhou Luo; Xiaojun Meng; Tian Tian; Leiwen Fu; Jianghong Dai; Huachun Zou
Journal:  Pathogens       Date:  2022-03-03

5.  Factors influencing HPV vaccination willingness among men who have sex with men in China: a structural equation modeling analysis.

Authors:  Haiying Pan; Wei He; Bing Lin; Xiaoni Zhong
Journal:  Hum Vaccin Immunother       Date:  2022-03-11       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.